Dr Christopher Hamill is categorized under Orthopedic Doctors and Physicians in Buffalo, NY and active since 2004.
Dr Christopher Hamill was established in 2004, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Orthopedic Doctors and Physicians business, which does work in the B2C market, and is classified as a Orthopedic Doctors and Physicians, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Christopher Hamill at the company’s single location by writing to 100 College Parkway, Buffalo, New York NY 14221 or by phoning (716) 204-0487. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Dr Christopher Hamill |
| Contact Person: | Christopher Hamill |
| Address: | 100 College Parkway, Buffalo, New York 14221 |
| Phone Number: | (716) 204-0487 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2004 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Orthopedic Doctors and Physicians |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Dr Christopher Hamill was started in 2004 to provide professional Orthopedic Doctors and Physicians under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Christopher Hamill for inquiries that concern Dr Christopher Hamill by calling the company number (716) 204-0487, as your correspondence is most welcome. Additionally, the physical location of the single location of Dr Christopher Hamill can be found at the coordinates 42.95911,-78.727926 as well as the street address 100 College Parkway in Buffalo, New York 14221.
For its online presence, you may visit Dr Christopher Hamill’s website at and engage with its social media outlets through on Twitter and on Facebook.